source
- BioCryst to shut internal drug discovery and close Alabama research siteBioCryst Pharmaceuticals announced it is winding down its internal drug discovery efforts. The company said it will seek future programs through external collaborations rather than in‑house resear…
- 5 takeaways from STAT’s investigation into microhospital operator Nutex HealthRead the takeaways from STAT's investigation into Nutex, which used the No Surprises Act to fuel a stunning financial turnaround.